Cerebral fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI, and clinical observations in a patient with infantile G(M1) gangliosidosis
Ma. Al-essa et al., Cerebral fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI, and clinical observations in a patient with infantile G(M1) gangliosidosis, BRAIN DEVEL, 21(8), 1999, pp. 559-562
The clinical, biochemical, pathological and neuroradiological findings of a
2-year-old Saudi buy with infantile G(M1) gangliosidosis are reported. The
patient had a progressive neurologic deterioration, manifesting with devel
opmental regression, sensorimotor and psychointellectual dysfunction and ge
neralized spasticity that started at 4 months of age. Cherry-red macula, fa
cial dysmorphia, hepatomegaly, exaggerated startle response to sounds, skel
etal dysplasia, and vacuolated foamy lymphocytes that contain finely fibril
lar material in addition to lamellar membranes and electron-dense rounded b
odies were seen. MRI of the brain demonstrated mild diffuse brain atrophy a
nd features of delayed dysmyelination and demyelination. Brain FDG PET scan
revealed a mild decrease in the basal ganglia uptake, and moderate to seve
re decrease in thalamic and visual cortex uptake, and an area of increased
glucose uptake in the left frontal lobe, probably representing an active se
izure focus. The functional changes indicated by FDG PET scan and the struc
tural abnormalities shown on MRI were found to be complementary in the imag
ing evaluation of infantile G(M1) gangliosidosis. (C) 1999 Elsevier Science
B.V. All rights reserved.